Post-approval studies (Phase 4)Study completedNCT03982381
What this trial is testing
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Uppsala University 2,067
Showing 20 of 116 results